DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Optison (Albumin Human) - Summary



Serious cardiopulmonary reactions, including fatalities, have occurred uncommonly during or following perflutren-containing microsphere administration. Most serious reactions occur within 30 minutes of administration (see WARNINGS and PRECAUTIONS).

  • Assess all patients for the presence of any condition that precludes OPTISON administration (see CONTRAINDICATIONS).
  • Always have resuscitation equipment and trained personnel readily available.


OPTISON™ (Perflutren Protein-Type A Microspheres Injectable Suspension, USP) is a sterile non-pyrogenic suspension of microspheres of human serum albumin with perflutren for contrast enhancement during the indicated ultrasound imaging procedures. The vial contains a clear liquid lower layer and a white upper layer that, after resuspension by gentle mixing, provides a homogeneous, opaque, milky-white suspension for intravenous injection.

OPTISON is indicated for use in patients with suboptimal echocardiograms to opacify the left ventricle and to improve the delineation of the left ventricular endocardial borders.

See all Optison indications & dosage >>


Media Articles Related to Optison (Albumin Human)

Doctors should stratify patients with suspected pulmonary embolism to determine diagnostic strategy
Source: Respiratory / Asthma News From Medical News Today [2015.09.29]
Overuse of computed tomography and D-dimer testing may not improve care and lead to patient harm and unnecessary expenseWhen evaluating patients with suspected acute pulmonary embolism (PE)...

ACP: Doctors should stratify patients with suspected PE to determine diagnostic strategy
Source: Blood / Hematology News From Medical News Today [2015.09.29]
Overuse of computed tomography and D-dimer testing may not improve care and lead to patient harm and unnecessary expenseWhen evaluating patients with suspected acute pulmonary embolism (PE)...

UCI researchers find biomarker for autism that may aid diagnostics
Source: Autism News From Medical News Today [2015.09.23]
By identifying a key signaling defect within a specific membrane structure in all cells, University of California, Irvine researchers believe, they have found both a possible reliable biomarker for...

Urgent change needed to improve diagnosis in health care or diagnostic errors will likely worsen
Source: Primary Care / General Practice News From Medical News Today [2015.09.23]
Most people will experience at least one diagnostic error -- an inaccurate or delayed diagnosis -- in their lifetime, sometimes with devastating consequences, says a new report from the Institute...

Most Americans Will Experience At Least 1 Diagnostic Error: Report
Source: MedicineNet Healthy Living Specialty [2015.09.23]
Title: Most Americans Will Experience At Least 1 Diagnostic Error: Report
Category: Health News
Created: 9/22/2015 12:00:00 AM
Last Editorial Review: 9/23/2015 12:00:00 AM

more news >>

Published Studies Related to Optison (Albumin Human)

Glycated albumin predicts the effect of dual and single antiplatelet therapy on recurrent stroke. [2015]
recurrence of stroke in patients on either dual or single antiplatelet therapy... CONCLUSIONS: GA could be a potential biomarker to predict the effects of dual and

Effects of combined lipoic acid and pyridoxine on albuminuria, advanced glycation end-products, and blood pressure in diabetic nephropathy. [2013]
This study was designed to investigate the effects of combined administration of lipoic acid and pyridoxine on albuminuria, oxidative stress, blood pressure, serum advanced glycation end-products, nitric oxide (NO), and endothelin-1 in patients with diabetic nephropathy.

High-dose albumin treatment for acute ischaemic stroke (ALIAS) Part 2: a randomised, double-blind, phase 3, placebo-controlled trial. [2013]
proportion of patients with a favourable outcome... INTERPRETATION: Our findings show no clinical benefit of 25% albumin in patients

Albumin resuscitation for traumatic brain injury: is intracranial hypertension the cause of increased mortality? [2013]
Mortality is higher in patients with traumatic brain injury (TBI) resuscitated with albumin compared with saline, but the mechanism for increased mortality is unknown...

Associations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study. [2011.07]
CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatinine ratio is independently associated with HbA1c and NT-proBNP, even in non-diabetic patients.

more studies >>

Clinical Trials Related to Optison (Albumin Human)

CeVUS With Intravesical Administration of OPTISON TM (Trademark) in Children [Recruiting]
In this clinical trial the investigators aim to evaluate the diagnostic feasibility and safety of ceVUS with the intravesical use of OPTISON for vesicoureteral reflux detection and urethral imaging in children.

A Prospective Surveillance Trial to Evaluate the Safety of Optison in Clinical Practice. [Completed]
This prospective surveillance trial will gather safety information for Optison when it is used in routine practice.

Regadenoson Real Time Perfusion Imaging Trial-Optison [Recruiting]
The purpose if this study is to examine how effective Regadenoson is in detecting coronary artery disease during a stress echocardiogram when Optison is administered. Optison is a contrast agent that improves the images of the heart on the echocardiogram (echo) machine. Optison is approved by the Food and Drug Administration (FDA) to use during stress echocardiograms. Regadenoson is a commercially available rapid acting stress agent that is used to chemically increase the heart rate and is approved for nuclear imaging tests. Regadenoson is a FDA approved drug but not for the intended use in this study.

Dose-Finding, Feasibility Study of Optison in Contrast Enhanced U/S for the Detection of Carotid Artery Disease [Terminated]

The purpose of this study is to find the optimal dose from 3 different dose levels - 0. 15

mL, 0. 5 mL and 1. 5 mL of Optison in assessing the presence of disease of the carotid arteries when comparing pre-contrast to post-contrast ultrasound (U/S) by dose group.

Evaluate Effect of Optison on Pulmonary Artery Systolic Pressure (PASP) and Pulmonary Vascular Resistance (PVR). [Completed]

more trials >>

Page last updated: 2015-09-29

-- advertisement -- The American Red Cross
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2015